|
|
|
|
||
Re: O'Brien QuoteThe agency can be an advocate and partner if a drug fills an underserved or unmet need. I have even seen them reach out to accelerate filings and approvals. I have spent much of my career working in the rare disease field and the interactions with the FDA are very different from the time I spent in larger pharma. I couldn't be happier to see NBIX focusing on unmet needs and I expect their valuation to continue to grow as they expand/progress their pipeline. |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
39296 | Re: O'Brien Quote | elan_bull | 0 | 5/21/2015 7:06:37 PM |